spironolactone (Aldactone) is beneficial for heart failure will change prescribing habits
August 1999
The exciting new finding that spironolactone (Aldactone) is beneficial for heart failure will change prescribing habits.
Researchers saw such significant improvement that they stopped the study early. The New England Journal of Medicine released the article over a month before it was scheduled to be published.
Adding spironolactone to the usual therapy for severe CHF improves symptoms...and reduces mortality and hospitalization by 30%.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote